Dear Sir Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in their meeting held on 14th November 2025 has considered and approved the following business: 1. Unaudited Financial Results of the Company for the quarter and half yearly ended on 30th September 2025
Omkar Pharmachem: Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November 2025
November 14, 2025
Download PDF
Omkar Pharmachem